Patents, Bio Rad Laboratories Inc, 10x Genomics, Microfluidics, Single Cell Sequencing.
damage. As a defense, 10X tried every possible means to invalidate the patents-in-suit. Normally it boils down to how to interpret or construct a few key claims and sometimes a few key words in the patents. The level of absurdity reached in such a “construction” is amusing to say the least.